The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Clinical trial NCT05208229 · TERMINATED

Trial details

NCT number: NCT05208229
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: TERMINATED
Study type: OBSERVATIONAL

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start date: 2021-02-01
Primary completion: 2022-03-08
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.